Current diagnosis and management of Zollinger-Ellison syndrome.
D K Andersen
https://pubmed.ncbi.nlm.nih.gov/2686566/Completed
Led by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Updated on 2026-08-04
273
Participants Needed
1
Research Sites
N/A
Total Duration
This protocol concerns the approach to the localization, diagnosis of MEN1 and management of the tumor and the tissue samples in patients with Zollinger-Ellison syndrome. It details the diagnostic imaging tests to be used to localize the tumor, investigations for MEN1 the subsequent management of the tumor and tissue samples for research.
CONDITIONS
Evaluating Pancreatic Tumors in Patients With Zollinger-Ellison Syndrome
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Lead Sponsor
New patients will be evaluated initially as described in the protocol entitled, "Diagnostic evaluation of patients with suspected abnormalities of gastric secretion" (89-DK-0005).
Only those patients that are being treated under the protocol entitled, "Medical Therapy of Zollinger-Ellison Syndrome" (protocol # 89-DK-0015) will be entered into this tumor localization and management protocol.
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
D K Andersen
https://pubmed.ncbi.nlm.nih.gov/2686566/W Creutzfeldt, R Arnold, C Creutzfeldt...
https://pubmed.ncbi.nlm.nih.gov/45919/M M Wolfe, R T Jensen
https://pubmed.ncbi.nlm.nih.gov/3309661/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Lead Sponsor